American Journal of Clinical Oncology-Cancer Clinical Trials

Article	Citations
Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy	64
Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients	24
Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy	24
Pharmacokinetics-Pharmacodynamics Modeling and Evaluation of Tumor Response to Bortezomib Proteasome Inhibitor in Waldenstrom Macroglobulinemia	23
Endpoint Governance and Reporting Transparency in Biomarker-Guided Oncology Trials	22
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma	18
The Impact of Patient, Disease, and Social Determinants of Health on Receipt of Nonoperative Management for Patients With Rectal Adenocarcinoma	15
Clinical Outcomes and Safety Profile of Adagrasib in KRAS G12C-Mutated Solid Tumors	15
Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors?	14
Death From Infection Among Patients Living With Cancer	14
The Landscape of Clinical Trials for Claudin18.2-Positive Gastric Cancer	14
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer	13
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer	13
Heart Disease Mortality After Primary Cancer Surgery in the United States	13
Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas	13
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy	12
Third-line Treatment for Metastatic Triple-negative Breast Cancer	12
Efficacy and Safety of Neoadjuvant Immunochemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma	11
Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus	11
Hypofractionated Radiation Therapy	11
Patient Navigation for Cancer Care in Sub-Saharan Africa	10
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer	10
Efficacy and Safety of Camrelizumab Plus Apatinib for Esophageal Squamous Cell Carcinoma	10
The Effect of Biomarkers on Clinical Trial Risk in Gastric Cancer	10
Beyond the Clinic	10

Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites	9
Outcome Predictors of Hardware Complications in Head and Neck Free Flap Reconstruction	9
ACR–ACNM–ARS–SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride	9
A Meta-analysis on Effects of Chimeric Antigen Receptor T-cell Therapy in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia	9
SBRT vs. Y90	9
Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases	9
Prospective Validation of An Inpatient Metastatic Spine Neoplasm Score To Assess the Optimal Radiation Therapy Intervention Modality	9
Early Cancer Screening Impressions of African-American Breast Cancer Patients Enrolled on the Navigator-Assisted Hypofractionation (NAVAH) Trial	8
Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy	8
Treatment of Cutaneous Adnexal Carcinoma With Radiotherapy	8
ACR–ARS Practice Parameter for Radiation Oncology	8
Crossover in Adjuvant Trastuzumab Trials	8
Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy	8
The Role of the Quality of Relationship in Couples Facing Treatment for Breast Cancer	8
Why Basic Science Education Matters in Radiation Oncology	7
Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients	7
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies	7
Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer	7
Treatment of Cancer Pain	7
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas	7
Accuracy of Medical Oncology Prognosis for Metastatic Cancer Patients Evaluated for Enrollment Onto an Ongoing Randomized Clinical Trial	7
Physician Assessment of ChatGPT and Bing Answers to American Cancer Society’s Questions to Ask About Your Cancer	7
Primary Central Nervous System Melanoma (pCNSM) and Treatment Protocols	7
Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer	7
The Role of Lactate Metabolism in Tumors	7
Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer	7
Effect of Treatment Delay on Outcomes With Adjuvant Chemotherapy Versus Chemoradiotherapy in R1-Resected Biliary Tract Cancers	6
Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk N Stage	6
Early Experience With Biologically Effective Dose-Comparable Short-Course Whole Brain Radiation Therapy for Metastatic Intracranial Disease	6
Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy	6
Overactive Bladder Symptoms in Cancer Patients Undergoing Chemotherapy	6
The Landscape of Clinical Trials for Targeting c-MET Therapy	6
Trends in Neoadjuvant Pembrolizumab Use in Triple-Negative Breast Cancer	6
Incidence and Risk of Second Primary Malignancies After Treatment for Papillary Thyroid Cancer	6
Brachial Plexus Constraints in Two-Fraction Spine Stereotactic Body Radiation Therapy	6
Quantification of Postdiagnosis Cancer Patient Navigation	6
Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma	6
Intramedullary Nailing Versus Compound Plate Osteosynthesis in Pathologic Diaphyseal Humerus Fractures	6
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors	5
Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer	5
Targeted and Chemo-Free Approaches in HER2-Positive Early Breast Cancer	5
Long-Term Outcomes After Abdominal Radiation for Wilms Tumor	5
Mortality Patterns of Esophageal Cancer in the United States	5
Does Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?	5
Three-Decade Trends and Future Projections of Malignant Skin Melanoma Burden in the United States and Globally	5
Laparoscopic Versus Abdominal Radical Hysterectomy	5
Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma	5
Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer	5
The Best Interest	5
Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer	5

Variation in Practice Patterns Among Radiation Oncologists Treating Oropharyngeal Cancers	4
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer	4
The microRNA-34 Family and Its Functional Role in Lung Cancer	4
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non–Small Cell Lung Cancer	4
The Concerning Disaggregation of Gender and Racial/Ethnicity Disparity Investigation at Recent ASCO Annual Meetings	4
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer	4
Long COVID in Cancer	4
Metaplastic Breast Carcinoma	4
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma	4
Single-Cell Transcriptomic Analysis Reveals γδ T-Cell Infiltration and Presence of Immune Regulatory Molecules in Biliary Tract Cancer Microenvironment	4
The Balance and Imbalance of Microbial Communities	4
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases	4
H-Index and Promotion in Academic Radiation Oncology	4
Geospatial Mapping of Head and Neck Cancer Research	4
Evaluation of Control Arm Quality in Recent Radiation Oncology Randomized Clinical Trials	4
Deep Learning-Based Risk Factor Analysis for Accurate Prediction of Lung Cancer in High-Risk Populations	4
FDA-Approved Radiopharmaceuticals in Oncologic PET Imaging	4
Emergence of Single-Week Adjuvant Radiation Therapy for Early-Stage Breast Cancer in the United States	4
Navigator-Assisted Hypofractionation (NAVAH) Phase I Clinical Trial of Breast Cancer Patients	4
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors	4
Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk Model	4
The Cost of Simplicity for Early-stage Breast Cancer Treatment	3
Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Mu	3
Transcranial Magnetic Stimulation (TMS) in Cancer Care	3
Efficacy and Safety of Probiotics as Adjunctive Therapy in Cancer Treatment	3
Stereotactic Body Radiation Therapy Combined With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma	3
Primary Synovial Sarcoma of the Abdomen and Pelvis	3
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy: Erratum	3
Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer	3
Five Fraction External Beam Partial Breast Irradiation	3
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients	3
Practice Patterns of Surveillance in Sentinel Lymph Node-Positive Malignant Melanoma	3
Proceedings of the American Radium Society® 104th Annual Meeting	3
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy	3
Complications of Implant-Based Reconstruction and Postmastectomy Radiation in the Era of Adjuvant CDK4/6 Inhibitors	3
Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	3
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer	3
National Trends and Disparities in Mortality From Early-Onset Pancreatic Cancer in the United States, 1999 to 2020	3
Beyond Treatment	3
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation	3
How Did We Get Here? The Progression From Frame-Based to Frameless Intracranial Stereotactic Radiosurgery	3
Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer	3
Evaluating the Safety and Efficacy of Adding Liver-Directed Radiation Therapy to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma	3
Clinicopathological Characteristics, Survival and Prognostic Factors in Gastrointestinal Large Cell Neuroendocrine Carcinoma	3
Advancing MRD Detection in Multiple Myeloma	3
Matched Cohort Analysis of Ultra-hypofractionated Versus Standard Fractionation Preoperative Radiation Therapy for Soft Tissue Sarcoma	3
Correspondence Letter to “Does Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?”	3
Dual Inhibition of HER2 and VEGF Pathways in Breast Cancer	3
Comorbidity and Risk of Complications and Readmissions Following Surgery for Patients With Renal Cell Carcinoma in the Military Health System	3
Prognostic Value of Multiparameter Biomarkers in Pleural Effusion of Patients With Non-small Cell Lung Cancer for Predicting Survival Outcomes	3
Prevalence and Development of Cachexia Before and After Diagnosis of Non–small Cell Lung Cancer	3
Advancements in Diagnosis and Multimodal Treatment Strategies for Retroperitoneal Tumors	3
Impact of Chemotherapy on Financial Toxicity in African American Breast Cancer Patients	3
A Novel Nomogram for Predicting Breast Cancer–specific Survival in Male Patients	3
Efficacy of Fibroblast Growth Factor Receptor Inhibitors (FGFRi) in Locally Advanced or Metastatic Cholangiocarcinoma With FGFR Fusions or Rearrangements	3
Executive Summary of the American Radium Society Appropriate Use Criteria	3
Efficacy and Safety of Antibody Drug Conjugates in Previously Treated Hormone Receptor Positive HER2 Negative (or Low) Metastatic Breast Cancer–A Systematic Review and Meta-Analysis	3
Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations	3
Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors	2
Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases	2
Real-world Safety of Concurrent Pembrolizumab and Radiotherapy in Triple-negative Breast Cancer	2
The Impact of Race and Ethnicity on Location and Delivery of Palliative Radiotherapy	2
Flap Reconstruction Results in Longer Overall Treatment Time in Patients Treated With Surgery and Adjuvant Radiotherapy for Carcinoma of the Oral Cavity and Larynx	2
A Preliminary Study of Immediate Intraperitoneal Chemotherapy for Stage III Colorectal Cancer	2
Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation	2
Real-World Outcomes of Adjuvant Immunotherapy and Radiation Therapy for Stage III Merkel Cell Carcinoma	2
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy	2
An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation	2
Accelerated Partial Breast Irradiation	2
Safety and Efficacy of Palbociclib and Endocrine Therapy Versus Endocrine Therapy Alone in HR+/HER 2− Breast Cancer Patients; a Systematic Review and Meta-Analysis	2
Predictors of an Academic Career in Radiation Oncology 5 to 10 Years After Residency	2
Surveillance Strategies in Follicular Non-Hodgkin’s Lymphoma’s Using Molecular and Genetic Markers Improve Cost-efficiencies Over Routine Imaging Studies	2
Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for the Use of Radiation in the Prevention and Treatment of Heterotopic Ossification (HO)	2
Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non–Small Cell Lung Cancer	2
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba	2
Clinical Features, Treatment Patterns, and Outcomes of Solitary Plasmacytoma in the United States	2
ACR–ARS Practice Parameter for the Performance of Stereotactic Body Radiation Therapy	2
Divergent Biliary Tract Cancer Trajectories	2
Targeted CysLTR1 Blockade Rescues Myeloid-Mediated Resistance to Immune Checkpoint Inhibition in Solid Malignancies	2
Meta-analysis of Therapeutic Approaches in Acute Myeloid Leukemia	2

Sentinel Node Navigation Surgery for Early Gastric Cancer	2
Racial Disparities in Endometrial Cancer Clinical Trial Representation	2
ACR–ABS–ACNM–ARS–SIR–SNMMI Practice Parameter for Radioembolization of Liver Malignancies	2
Long-term Locoregional Control With Unilateral Radiation for AJCC-7 T1-2N2b Tonsillar Cancer	2
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction	2
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity	2
Regional Variation in Access to Oncologic Care and Racial Disparities Among Cervical Cancer Patients	2
The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma	2
Standard Versus Extended Pelvic Lymphadenectomy in Patients With Bladder Cancer	2
Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy	2
Development and Validation of Palmitoylation-Related Genes in the Prognostic and Immunologic Characterization of Lung Adenocarcinoma	2
Bombarding Oligoprogression	2
Assessing the Rate and Quality of Breast Cancer Treatment Following Initial Diagnosis	2
Prognostic Relevance of Negative Lymph Node Count in Resected Stage I–IIIa Small-cell Lung Cancer	2
Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum	2
Targeting HCC With SBRT	2
Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography	2
Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell Lung Cancer	2
The Role of Social Determinants of Health in the Receipt of Systemic Treatment for Metastatic Melanoma	2
Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma	2
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases	2
Circulating DNA in Rectal Cancer to Unravel the Prognostic Potential for Radiation Oncologist	2
KRAS Mutations in Cancer	2
Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer	2
Efficacy of Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer	2
ACR–ARS Practice Parameter for Communication	1
Metabolic Plasticity in Prostate Cancer	1
ACR–ARS Practice Parameter for the Performance of Total Body Irradiation	1
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer	1
Rising Pancreatic Adenocarcinoma and Type 2 Diabetes Mellitus-Related Mortality in the United States, 2000 to 2024, With Forecasts to 2034	1
Targeted Therapies in Non–Small Cell Lung Cancer	1
Statewide Social Vulnerability Index (SVI) in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma	1
Modifiable Lifestyle Risk Factors in Adult Survivors of Childhood Cancer	1
Advancements in Cutaneous T-Cell Lymphoma Treatment	1
Upper Extremity Lymphedema​​​	1
Advancements in NSCLC	1
The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease	1
Impact of Sequencing of Treatment Modalities on Survival in Nonmetastatic Hepatocellular Carcinoma	1
Wilms’ Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5	1
Relevance of Chemokines in Mobilizing γδ T Cells in the Biliary Tract Cancer Microenvironment: Potential for γδ T-Cell–Based Adoptive Cell Therapy	1
Genetic Alterations in NSCLC	1
A Review of Endocrine Therapy in Early-stage Breast Cancer	1
Executive Summary of the American Radium Society Appropriate Use Criteria for the Use of Esophageal Stents in Patients With Esophageal Cancer	1
Local Control Outcomes of Patients With Brain Metastases From Small Cell Lung Cancer Treated With Stereotactic Radiosurgery	1
Outcomes of Patients With Esophageal and Gastric Carcinoma at a Safety-net Health Care System	1
Global Trends in Childhood Acute Lymphoblastic Leukemia Burden and Quality of Care Inequalities Across Regions, 1990 to 2021	1
Vitamin C as an Adjunctive Therapy in Cancer	1
Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+ and HER2-low Breast Cancer	1
Hepatobiliary Toxicity Following Ablative Radiation for Centrally Located Hepatocellular Carcinoma	1
Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation	1
Censoring Analysis of the INvestigating VorasiDenib In GliOma (INDIGO) Phase III Randomized Controlled Trial	1
Proceedings of the American Radium Society® 106th Annual Meeting	1
Risk Factors for Recurrence and the Role of Radiotherapy in Low-grade Myofibroblastic Sarcoma	1
Letter to Editor on Qureshi et al. Efficacy and Safety of Abemaciclib in Combination with Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer a Systematic Review and Meta-Analysis, Am	1
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma	1
Success of Ultra-low Dose Radiation Therapy for Primary Cutaneous B-cell Lymphoma	1
Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma	1
Management Strategies and Outcomes in Primary Liver Angiosarcoma	1
Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial Cancer Based on the Platinum-free Interval	1
Early Detection of Colorectal Cancer Following Changes to Screening Guidelines	1
Effect of Continuous Nutritionist-led Guidance on Bowel Preparation in Patients Undergoing Prostate Stereotactic Body Radiation Treatment With Endorectal Spacing	1
Rituximab as a Therapeutic Strategy in Hemophagocytic Lymphohistiocytosis: Efficacy, Outcomes, and Survival—Insights From a Systematic Review	1
Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer	1
Comparative Efficacy and Safety of Bispecific T-Cell Engagers (BiTEs) Versus Immune Checkpoint Inhibitors (ICIs) in Hematologic Malignancies	1
Cardiovascular Risk Profile of Nivolumab Anti-cancer Therapy	1
Empowering Self-advocacy for Breast Health	1
AI Prognostication in Nonsmall Cell Lung Cancer	1
Comprehensive Analysis of Conditional Survival in Radiation-treated Patients With Gynecologic Malignancies Using the SEER Database	1
Bytes to Blood—Artificial Intelligence in the Management of Leukemia	1
Conditional Survival Estimates for Malignant Glioma Patients	1
Prostate Brachytherapy With Cs-131	1
Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict Aggressive Behavior: Erratum	1
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non–Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy	1
Predictors of Survival in Patients With Hepatocellular Cancer Receiving Atezolizumab and Bevacizumab	1
Research Progress of SBRT Combined With Immunotherapy in Locally Advanced Head and Neck Cancer	1
Stereotactic Radiosurgery for Vestibular Schwannoma With Radiographic Brainstem Compression	1
Bevacizumab Combination Therapy Versus Standard Chemotherapy for Ovarian Cancer in Shorter and Longer Follow-Up Duration	1
Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes	1
Optimizing Natural Killer Cellular Therapy in Acute Myeloid Leukemia	1
Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant	1
Small Bowel Cancer-Related Mortality in the United States, 1999 to 2024	1
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Low-Dose Radiotherapy for Treatment of Osteoarthritis	1
Risk Factors for Postoperative Venous Thromboembolism in Patients With Gynecologic Malignancies	1
Predictive Value of PIK3CA Mutations for Response to CDK4/6 Inhibitors in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer	1
Impact of Minimal Residual Diseases Status and Depth of Response on Survival Outcomes in Blinatumomab-Treated Acute Lymphoblastic Leukemia	1
Impact of Interruptions in Chemotherapy on Survival for Patients With Metastatic or Recurrent Cervical Cancer	1
Predicting and Optimizing Synergistic Drug Combinations for Breast Cancer Treatment Using Machine Learning	1
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer	1
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer	1
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy	1
A Phase II Trial to Assess the Evolution of the KRAS Mutation Load by Liquid Biopsy in Patients With Resectable Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant NALIRIFOX	1
Efficacy and Safety of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	1
Maintenance Therapy in Acute Myeloid Leukemia	1